We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure coreplatform@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
The history and management of an intensive care patient suffering from systemic infection or sepsis or a patient who is in danger of becoming septic is totally different from that of a patient who will receive, or has received, a transplant. A patient who is registered on the waiting list for heart and/or lung transplantation has been chronically ill for months and even years. Patients waiting for a heart have circulatory and respiratory problems, multiple organ dysfunction and often show signs of immune depression. Lung transplant patients, however, have a long history of cystic fibrosis with all its associated infections, or have suffered from chronic bronchitis, emphysema or idiopathic fibrosis. All such patients have been under intensive medical care and observation and their underlying disease known and heavily and specifically treated. All transplant patients have to undergo major surgery with a long period of anaesthesia and extended trauma; they often receive multiple blood transfusions from foreign donors. After surgery, the patient experiences aggressive and chronic immunosuppression. Azathioprine, cyclosporin, tacrolimus and steroids are given within the first 7 days and remain at relatively high doses for another month. A rejection episode, which occurs in more than 60% of all transplant patients, needs an immediate boost of immunosuppression. Under this antirejection treatment, patients are at a significant risk of developing opportunistic infections.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.